Category Archives: FDA Alert

March 12, 2012 | by MH

FDA Safety Alerts – Dangerous Drugs & Defective Products Info

MedWatch, the FDA’s Safety Information and Adverse Event Reporting Program has been busy, as usual. February alone included the following Safety Alerts about dangerous drugs and defective products— • Important safety label changes for the class of cholesterol-lowering drugs known … Continue reading →

September 30, 2011 | by MH

Deadly Listeria Outbreak — FDA Alert Issued

The FDA has issued an alert about the recall on whole cantaloupes that were distributed by Jensen Farms (no relation to Mitch Jensen). The recalled cantaloupes were shipped between July 29 and September 10, 2011 to the following states: Arizona, … Continue reading →

September 7, 2011 | by Shirley

Actos (pioglitazone) and Bladder Cancer – FDA Warning

Actos (pioglitazone) is one of the largest-selling oral medications sold to control blood sugar levels. Millions of prescriptions for this medication are filled each year by diabetics. Because of the millions of prescriptions written for this medication, when the FDA recently issued … Continue reading →

May 11, 2011 | by Siegfried & Jensen

Topamax and Topiramate Linked to Birth Defects — FDA Warning

Topamax and it’s generic, topiramate, are anti-convulsant medications that can help prevent or minimize certain types of seizures, as well as migraine headaches. According to the FDA, approximately 32.3 million prescriptions were dispensed for these drugs between January 2007 and … Continue reading →

December 30, 2010 | by Valerie Swaner

Darvon & Darvocet (Propoxyphene) Withdrawn by FDA

The consumer safety watchdog group, Public Citizen’s Health Research Group have been lobbying the FDA for years. Their efforts first began in 1978 when they urged the FDA to ban the drugs Darvon & Darvocet on the basis of dangerous side effects to the heart. Continue reading →